Who We Are
340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.Learn more about us
Meet Michael, Our Newest Patient Face of 340BClick here to watch
Visit The Exchange today to connect with over 9,000 of your 340B colleagues on the topics that matter most.Click here to post
January 21, 2021– A new, bipartisan report from a key congressional committee is sharply critical of the three major drug manufacturers that sell insulin in the U.S. The companies – Eli Lilly, Novo Nordisk, and Sanofi – already have been all over the news recently for their pricing...